Studies on p66Shc deletion in vitro in cell types other than pancreatic beta-cells have provided further data supporting the possible role of p66Shc in the pathogenesis of diabetes, mainly due to its insulin-signaling repressor activity [45]. The gene discussed is INS; the disease is diabetes mellitus.